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a b s t r a c t
Genome-wide epigenetic reprogramming is required for successful preimplantation development.
Inappropriate or deﬁcient chromatin regulation can result in defective lineage speciﬁcation and loss of
genomic imprinting, compromising normal development. Here we report that two members of the RNA
polymerase II associated factor, homolog (Saccharomyces cerevisiae) complex (PAF1 complex) compo-
nents, Ctr9 and Rtf1, are required during mammalian preimplantation development. We demonstrate
that Ctr9-deﬁcient embryos fail to correctly specify lineages at the blastocyst stage. Expression of some
lineage speciﬁc factors is markedly reduced in Ctr9 knockdown embryos, including Eomes, Elf5 and Sox2,
while others are inappropriately expressed (Oct4, Nanog, Gata6, Fgf4 and Sox17). We also show that
several imprinted genes (Mest, Peg3, Snrpn and Meg3) are aberrantly expressed although allele speciﬁc
DNA methylation is not altered. We document a loss of histone H3 lysine 36 trimethylation (H3K36me3)
in Ctr9-deﬁcient embryos and conﬁrm that knockdown of either Setd2 or Rtf1 results in similar
phenotypes. These ﬁndings show that the PAF1 complex is required for mammalian development, likely
through regulation of H3K36me3, and indicate functional conservation of the PAF1 complex from yeast
to mammals in vivo.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Fusion of the highly differentiated mammalian oocyte and sperm
results in the formation of a totipotent zygote that initiates embry-
ogenesis. During preimplantation development, critical genome-wide
epigenetic reprograming occurs to ensure successful embryonic devel-
opment, including maintenance of genomic imprinting and establish-
ment of pluripotency (reviewed in (Hemberger et al., 2009; Surani
et al., 2007)).
Through a phenotype-driven RNAi screen, we identiﬁed mouse
Ctr9, PAF1/RNA polymerase II complex component, homolog
(S. cerevisiae) (Ctr9) as being required for developmental and
epigenetic events during preimplantation development. CTR9 is a
component of the PAF1 complex (PAF1c), which consists of the
5 core proteins PAF1, RTF1, CTR9, CDC73 and LEO1. The PAF1c was
ﬁrst identiﬁed in yeast where it has been shown to prevent
transcriptional activation and regulate cell cycle (Koch et al., 1999).
The yeast complex is also required for COMPASS-mediated H3K4
methylation and Dot1-mediated H3K79 methylation (Krogan et al.,
2003a) as well as appropriate polyadenylation of some transcripts
(Penheiter et al., 2005). Additionally, maintenance of histone
H3K4me3 and H3K36me3 have been shown to require functional
PAF1c in both yeast and human cells (reviewed in (Jaehning, 2010)).
Adding to the challenges in understanding the biological role of
PAF1c, the complex can also recruit CHD1, an ATP-dependent
chromatin-remodeling enzyme.
Deletion of Paf1 and Ctr9 in yeast leads to aberrant cell growth and
cell cycle control (Koch et al., 1999). PAF1c associates with RNA pol II at
coding regions during transcription elongation and has been shown to
promote phosphorylation of the RNA pol II C-terminal domain
(Nordick et al., 2008). Furthermore, the PAF1c is crucial for appropriate
transcription termination and 3′ mRNA end formation (Nordick et al.,
2008). Currently, the mechanistic role of PAF1c during mammalian
development in vivo remains largely unexplored.
Recently, both Ctr9 and Rtf9 were identiﬁed in an RNAi screen
in embryonic stem cells (ESCs) as regulators of pluripotency (Ding
et al., 2009). Ding et al. showed in ESCs that PAF1c components
bind to the promoters of Oct4, Nanog and Sox2, which are essential
to maintain ES identity, and that knockdown (KD) of Ctr9 or Rtf1
resulted in premature differentiation – speciﬁcally to endoderm
in vitro. One member of PAF1c, Cdc73 (also called Paraﬁbromin and
Hrpt2), has been knocked out in the mouse and results in peri-
implantation lethality as well as lethality when conditionally
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deleted in adult animals (Wang et al., 2008). Additionally, compo-
nents of PAF1c have been shown to be required for heart and
neural crest development in zebraﬁsh (Langenbacher et al., 2011),
developmental Hedgehog, Notch and Wnt signaling in ﬂies (Bray
et al., 2005; Mosimann et al., 2009; Tenney et al., 2006), as well as
immune response and cancer progression in human cell lines
(reviewed in (Tomson and Arndt, 2013)).
Here, we show that Ctr9 and Rtf1 are present in morula and
blastocyst stage embryos and are necessary for normal preim-
plantation lineage identity and function. Ctr9-deﬁcient embryos
fail to form trophoblast outgrowths, and the differentiation potential
of the ICM is suppressed. Some key lineage speciﬁc factors are
reduced in the absence of Ctr9, including Eomes, Elf5 and Sox2, while
others are inappropriately expressed (Oct4, Nanog, Gata6, Fgf4 and
Sox17). Importantly, H3K36me3 was reduced in Ctr9-deﬁcient
embryos, indicating functional conservation of PAF1c from yeast to
mammals in vivo.
Materials and methods
Production and culture of embryos
Superovulation of B6D2 F1 female mice (8 to10 weeks old) was
performed using 10 IU PMSG (Sigma) followed by 10 IU hCG
(Sigma) 46–48 h later. At 20–22 h post-hCG treatment, zygotes
were collected from B6D2 F1 female mice mated to B6D2 F1 males.
For allele speciﬁc analysis, widely derived mouse strains were
used to distinguish parental alleles by transcribed SNPs – B6D2F1
dams were mated to PWD (mus. Molossinus) stud males. Hyalur-
onidase (ICN Pharmaceuticals, Costa Mesa, CA, USA) was used to
remove cumulus cells. Zygotes were cultured in KSOM at 37 1C/5%
CO2/5% O2 balanced in N2 in a mixed gas incubator. Use of
vertebrate animals for embryo production was in accordance with
the University of Massachusetts IACUC.
Outgrowth assay
After removal of zona pellucida, blastocysts were cultured
individually in 10% DMEM inwells coated with 0.1% gelatin (Sigma).
For ICM isolation, blastocysts were treated with anti-mouse anti-
serum, washed and exposed to guinea pig complement sequentially
as described by (Solter and Knowles, 1975). The isolated ICMs were
cultured individually inwells plated with 0.1% ﬁbronectin. Outgrowths
(intact blastocysts or isolated ICMs) were cultered at 37 1C/5% CO2 in
air and were observed for three days.
Double-stranded RNA (dsRNA) preparation
DNA templates for T7-RNA polymerase mediated dsRNA produc-
tion were ampliﬁed from genomic DNA or preimplantation embryo
cDNA using primers that contained the T7 binding sequences
followed by gene speciﬁc sequences as follows: dsGfp Forward:
TAATACGACTCACTATAGGGCACATGAAGCAGCACGACTT and Reverse:
TAATACGACTCACTATAGGGTGCTCAGGTAGTGGTTGTCG,dsCtr9-1
Forward: TAATACGACTCACTATAGGGCCATTTGGCAAACCACTTTT and
Reverse:TAATACGACTCACTATAGGGAAGGGCACCCTGTATGTCAG,dsC
tr9-2Forward:TAATACGACTCACTATAGGGCCATGGCCAGAGATAAAGG
AandReverse:TAATACGACTCACTATAGGGCGAAAACATCACGAGCTT
CA,dsRtf1Forward:TAATACGACTCACTATAGGGCATGAAGAAGCAAGC-
CAACA and Reverse: TAATACGACTCACTATAGGGAACGCCGTTCTTTA
TTGTGG,dsSetd2Forward:TAATACGACTCACTATAGGGGATGGCTTG-
CACTCATCAGA and Reverse: TAATACGACTCACTATAGGGTCTCCAA
CTCTTGCCTTCGT. dsRNA apmicons were BLASTed against the
mouse genome to ensure the target sequence had less than 19-
mer homology with any non-target transcripts. PCR products were
puriﬁed by gel extraction (Qiagen spin column-Qiagen ♯ 28106). In
vitro transcription was performed using T7 MEGAscript Kit (Ambion
product ♯ AM1334) and 0.5 μl of TURBO RNase-free DNase was
added to each 10 μl reaction to remove the DNA template. dsRNA
was treated with NucAway Spin Columns (Ambion product ♯
AM10070) to recover the dsRNA while removing salts and unin-
corporated nucleotides. The dsRNAwas then extracted with phenol:
chloroform and precipitated with 70% ethanol and resuspended in
RNase free water. The quality of dsRNA was conﬁrmed by electro-
phoresis (after in vitro transcription as well as after precipitation).
The concentration of dsRNA was measured by Nanodrop and
diluted to 1 μg/μl and stored at 80 1C.
Microinjection
dsRNA was microinjected into the cytoplasm of zygote using a
Piezo-drill (Prime Tech, Japan) and Eppendorf transferman micro-
manipulators. 1 mg/ml dsRNA were loaded into microinjection
pipette and constant ﬂow was adjusted to allow successful micro-
injection. Approximately, 5–10 pl dsRNA was injected into the
cytoplasm of each embryo. For dsOct4 rescue experiment, 25 ng/
ml dsOct4 was co-microinjected with dsCtr9.
RNA extraction, PCR and real-time PCR
Total RNA from embryos (n¼5–10/pool) was extracted using
the Roche High Pure isolation kit (Roche product ♯ 1828665). cDNA
synthesis was performed using M-MLV Reverse Transcriptase
(product ♯ M1701). To quantify gene expression differences
between KD and control groups, real-time PCR was performed
on a Stratagene MX3005p using Applied Biosystems Gene Expres-
sion Assays and Quanta Supermix (product ♯ 95078) probe based
reactions. All qPCR reactions included Gapdh Vic-labeled multiplex
control. One embryo equivalent of cDNA was used for each real-
time PCR reaction with a minimum of three replicates for all
results shown. Taqman Gene Expression Assays from Applied
Biosystems used: Ctr9, Mm00493862_m1; Rtf1, Mm01324605_m1;
Setd2, Mm01250225_m1; Elf5, Mm00468732_m1; Eomes, Mm013-
51985_m1; Mest, Mm00485003_m1; Peg3, Mm01337379_m1; Snrpn,
Mm02391920_g1; Cdx2, Mm01212280_m1; Oct4, Mm00656129_gH;
Nanog, Mm01617761_g1; Sox2, Mm00488369_s1. Unless otherwise
stated, quantiﬁcation was normalized to Gapdh (ABI, 4352339E-080
6018) mRNA.
Immunoﬂuorescence
Preimplantation embryos were ﬁxed with 4% paraformaldehyde
in PBS for 25 min at room temperature, permeabilized with 0.2%
Triton X-100 for 25 min, then blocked in 10% FBS/0.1% Triton X-100/
PBS for 1 h after 3 times washing in 0.1% Triton X-100 PBS, and
incubated with antibodies for 1 h at room temperature or overnight
at 4 1C followed by incubation with Alexa Flour secondary antibodies
488, 543, 647 (Invitrogen) at 37 1C for 1 h. DNA was stained with
DAPI and samples were mounted and observed with the Nikon
Eclipse TE-2000-S microscope (Nikon). Identical image capture
settings were used for embryos in experiment. Antibodies used are
listed as follows: Immunogen (Vendor, Catalog ♯, Dilution, and
Species). CDH1 (Abcam, Ab53033, 1:200, Rabbit); CDX2 (Biogenex,
AM392-5 M, 1:200, Mouse); CTR9 (Abcam, Ab84487, 1:200, Rabbit);
ELF5 (Santa Cruz, sc9645, 1:100, Goat); EOMES (Abcam, Ab23345,
1:200, Rabbit); GATA6 (R&D Systems, AF1700, 1:200, Goat);
H3K36me3 (Abcam, Ab9050, 1:200, Rabbit); H3K4me3 (Abcam,
Ab8580, 1:200, Rabbit); H3K9me3 (Abcam, Ab8988, 1:200 Rabbit);
NANOG (CosmoBio, RCAB0002P-F, 1:200, Rabbit); OCT4 (Santa Cruz,
sc5279, 1:200, Mouse); SOX17 (R&D Systems, NL1924R, 1:300, Goat);
and SOX2 (Santa Cruz, sc17320, 1:200, Goat). For IF experiments, we
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performed at least 3 replicates with at least 3 embryos/group with
each antibody combination (although typically groups of 5–10 were
used). We only present results where at least 75% of embryos show
the same/similar result.
Bisulﬁte sequencing
Bisulﬁte sequencing of Mest (GenBank™ accession number
AF017994; nucleotides 2220–2556) and Peg3 DMRs (NT_039413.7;
3683033–3682588) was done as follows: Groups of 3–7 blastocysts
were lysed and bisulﬁte-converted according to the manufacturer's
instruction using (EZ DNA Methylation-Direct™ Kit, Zymo). Bisulﬁte
converted DNA primers were used: Mest outside forward: GATTTGG-
GATATAAAAGGTTAATGAG, outside reverse: TCATTAAAAACACAAA-
CCTCCTTTAC; inside forward: TTTTAGATTTTGAGGGTTTTAGGTTG,
inside reverse: AATCCCTTAAAAATCATCTTTCACAC; Peg3: outside for-
ward: TTTTGATAAGGAGGTGTTT, outside reverse: ACTCTAATATCCAC-
TATAATAA; inside forward: AGTGTGGGTGTATTAGATT, inside reverse:
TAACAAAACTTCTACATCATC. Oct4 bisulﬁte assay exactly as previously
published (Hattori et al., 2004) with primers, PRO F, 5′-TGGGTTGAAA-
TATTGGGTTTATTT-3′; PRO R, 5′-CTAAAACCAAATATCCAACCATA-3′.
One-half embryo equivalent of the mutagenized DNA was used for
each ﬁrst round PCR reaction. 5 μl of ﬁrst round PCR product was
used as template for second round PCR reactions. The PCR products
were subcloned into pCRsII-TOPOs (Invitrogen) and individual
clones were sequenced by Eton Biosciences Inc. Sequence data was
analyzed using CodonCode Aligner software.
Allele speciﬁc assays
Meg3 RFLP: RT-PCR was performed with intron spanning primers:
Meg3-Lc: CACGGACACAGACACCTGC and Meg3-Lb: AAGCACCATGAG
CCACTAGG in order to amplify a product containing a useful SNP
(position 834 in ENSMUSG00000021696, B6¼A, PWD¼G). Restric-
tion digestion with Bsrd1 was performed in order to resolve parental
speciﬁc bands on a 0.7% acrylamide gel (Maternal B6¼321 and 33
base pair bands, Paternal PWD¼354 base pair uncut amplicons).
Mest RFLP: RT-PCR was performed with intron spanning primers:
Peg1_F1: 5′-TTCGCAACAATGACGGCAAC-3′ and Peg1_R1: 5′-GAGGTG-
GACTATTGTGTCAC-3′ in order to amplify a product containing a useful
SNP (position 1021 in ENSMUSG00000051855, B6¼G, PWD¼A).
Restriction digestion with Xmn1 was performed in order to resolve
parental speciﬁc bands on a 0.7% agarose gel (Maternal B6¼422 and
63 base pair bands, Paternal PWD¼485 base pair uncut amplicons).
Statistical analysis
All experiments were repeated at least three times unless
otherwise stated. Student t test was used to evaluate the difference
between groups and a value of Po0.05 was considered to be
statistically signiﬁcant. Data are expressed as mean7s.e.m.
Results
Expression of Ctr9 in preimplantation embryos
Ctr9mRNAwas detected in all stages examined during preimplan-
tation development (Fig. 1A), with highest levels at the 4-cell and
8-cell stage, and a dramatic reduction in morula and blastocysts. This
pattern suggests Ctr9 is zygotically transcribed and that only limited
maternal Ctr9 (if any) contributes to preimplantation development.
Immunoﬂuorescent (IF) analysis revealed no nuclear localization of
CTR9 during cleavage stages, with the highest accumulation in nuclei
of morulae, and then reduced (but present) signal in blastocysts
Fig. 1. Efﬁcient depletion of Ctr9 in preimplantation embryos. (A) qPCR analysis shows that Ctr9mRNA is present throughout preimplantation development. (B) CTR9 protein
is detected in nuclei of morulae and blastocysts but not during cleavage stages. (C) Endogenous Ctr9 mRNA is signiﬁcantly depleted by dsCtr9 injection. Asterisks indicate
Po0.05. Error bars represent SEM. (D,E) CTR9 protein is efﬁciently knockdown in morula (D, 11 dsGFP and 10 dsCtr9 examined) and blastocysts (E, 9 dsGFP and 12 dsCtr9
examined) after microinjection of dsCtr9. O, MII oocytes; 1c, 1-cell stage; 2c, 2-cell stage; 4c, 4-cell stage; 8c, 8-cell stage; Mo, morula; Bl, blastocyst stage. Scale bar: 50 μm.
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(Fig. 1B). The exclusive detection of CTR9 protein in morula and
blastocysts is consistent with the highest Ctr9mRNA at slightly earlier
stages. This dynamic expression pattern suggests precise regulation of
CTR9 function, at both the mRNA (transcriptional) and protein
(translational and/or degradation) levels within blastomeres. CTR9
was detected in all blastomeres of morula and blastocysts, and no
difference in localization was detected between inner cell mass (ICM)
and trophectoderm (TE).
Fig. 2. CTR9 deﬁciency results in failure of trophectoderm outgrowth. (A) Typical outgrowths are observed in control embryos after 3 days in culture (A, circle in upper
panel). Failure of blastocyst outgrowth was observed in dsCtr9 embryos (A, lower panel). Scale bar: 20 μm. (B) Quantiﬁcation of outgrowth potential for dsGfp and dsCtr9
embryos (21 dsGfp and 28 dsCtr9 blastocysts were analyzed). (C–E) Expression of trophectoderm speciﬁc genes Cdx2 (C), Eomes (D) and Elf5 (E) in dsGfp and dsCtr9 embryos
at morula and blastocyst stages (5–10 embryos/pool, two independent experiments). Asterisks indicate Po0.05. Error bars represent SEM. (F) EOMES and ELF5 protein are
reduced in dsCtr9 blastocysts. ICM area is circled with dotted line. Scale bar: 50 μm. (G) Graph representing percent EOMES positive or ELF5 positive cells in dsGfp and dsCtr9
blastocysts (EOMES: 12 dsGfp and 12 dsCtr9 examined; ELF5: 7 dsGfp and 9 dsCtr9 embryos examined). Asterisks indicate Po0.05. Error bars represent SEM.
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Efﬁcient depletion of CTR9 by microinjection of dsRNA
We routinely microinject double-stranded RNA designed against
speciﬁc transcripts (dsRNA) into zygotes to silence genes of interest
by RNAi (Maserati et al., 2011, 2012; Zhang et al., 2013). This
approach has been widely demonstrated as a robust tool to achieve
RNAi in mammalian preimplantation embryos without off-target
effects (Svoboda et al., 2000; Wianny and Zernicka-Goetz, 2000).
Microinjection of dsCtr9 greatly reduced endogenous Ctr9 mRNA
abundance at all stages examined (Fig. 1C). Furthermore, CTR9
protein was undetectable in nuclei of dsCtr9 morula (Fig. 1D,
control: n¼11, KD: n¼10) and blastocysts (Fig. 1E, control: n¼9;
KD: n¼12) after dsCtr9 injection.
Loss of CTR9 compromises both TE and ICM outgrowth potential
We observed normal blastocyst formation rates and blastocyst
morphology in dsCtr9 embryos. When cultured in vitro for three
additional days, the majority of control blastocysts (18/21 dsGFP)
hatch and form outgrowths with characteristic trophoblast giant
cells and a single stalk- like colony of ICM cells (Fig. 2A, upper
panel and B). However, only one quarter (7/28) of Ctr9 KD embryos
form blastocyst outgrowths, while the majority (21/28) remain
with blastocyst-like morphology (Fig. 2A, lower panel and B).
dsCtr9 embryos that did show outgrowth were markedly reduced
in both overall size of outgrowth area and cell number. In order to
conﬁrm that the observed defects were due to loss of Ctr9,
microinjection of a second, non-overlapping dsRNA against Ctr9
showed the same outgrowth defects (not shown).
Trophectoderm lineage defects in dsCtr9 embryos
The failure of Ctr9-deﬁcient blastocysts to form outgrowths
suggested a defect in proliferation or differentiation of the trophec-
toderm (TE). However, cell counting revealed normal numbers of
cells (both total and ICM, Supplemental Fig. 1A) in dsCtr9 embryos,
suggesting that defects in proliferation are not a major factor. We
therefore assessed Cdx2, Eomes and Elf5 expression (genes required
for trophectoderm lineage identity (Donnison et al., 2005; Niwa et al.,
2005; Russ et al., 2000, Strumpf et al., 2005)) by qPCR and IF.
No signiﬁcant differences were found in Cdx2 expression (Fig. 2C) or
localization (Fig. 1D). CDX2 expression in dsCtr9 embryos indicated
that TE are speciﬁed and present. However, both Eomes and Elf5,
were notably reduced in Ctr9-deﬁcient blastocysts by both qPCR
(Fig. 2D,E) and IF (Fig. 2F,G, Eomes: control: n¼12 and KD: n¼12;
Elf5: control: n¼7 and KD: n¼9). These data suggest that while TE
cells are speciﬁed from ICM in the absence of Ctr9, their molecular
identity is compromised, which likely contributes to their outgrowth
failure.
Molecular defects in dsCtr9 inner cell mass
To evaluate the developmental potential of Ctr9-deﬁcient
pluripotent cells, ICM cells were isolated by immunosurgery and
cultured on ﬁbronectin plates which has been shown to enhance
PE growth/differentiation (Behrendtsen et al., 1995). After 3 days,
wild type ICM outgrowths have visible parietal endoderm cells
(derivatives of primitive endoderm (PE) cells) migrating away
from the ICM colony (as reported by others (Behrendtsen et al.,
1995), arrow in Fig. 3A). However, the majority of Ctr9-deﬁcient
ICMs showed no evidence of PE outgrowth (Fig. 3A, lower left and
3B) or markedly reduced numbers of cells (Fig. 3A, lower right and
3C). This result suggests defects in both ICM potential as well as PE
differentiation in the absence of Ctr9 function.
We next examined molecular markers of pluripotent cells in
control and dsCtr9 embryos. qRT-PCR revealed that Oct4 mRNA
was consistently increased from the 8-cell to blastocyst stage in
dsCtr9 embryos (Fig. 3D), while Nanog and Sox2 mRNA were
unchanged in Ctr9 KD embryos (not shown). IF analysis also
revealed increased OCT4 signal intensity in OCT4-positive blasto-
meres at the morula stage as well as in presumptive TE (outer
cells) at the blastocyst stage (Fig. 3E and F).
It has been previously established that suppression of Oct4 in
trophectoderm stem cells is controlled by epigenetic modiﬁcation
to the locus, including DNA methylation (Hattori et al., 2004). We
examined the DNA methylation status in the Oct4 promoter in
control and KD embryos. However, we observed no DNA methyla-
tion in either control or KD embryos (Supplemental Fig. 1B),
suggesting that the regulation of Oct4 expression in trophecto-
derm by CTR9 in vivo is independent of DNA methylation.
In order to test the possibility that OCT4 overexpression
contributes to the outgrowth failure of dsCtr9 embryos, we
microinjected dsCtr9 plus a titrated amount of dsOct4. As antici-
pated, reduction of Oct4 partially restored the outgrowth potential
in embryos lacking CTR9 (Fig. 3G–I), indicating that mis-regulation
of OCT4 levels does indeed alter the potential of dsCtr9 embryos.
In control embryos, NANOG becomes restricted to epiblast (EPI)
cells in late blastocysts (Fig. 4A, upper panel, n¼13). Interestingly,
in addition to EPI expression, ectopic NANOG was detected in
some TE cells in the absence of Ctr9 (Fig. 4A, arrows lower panel,
n¼21). In contrast, SOX2 positive nuclei, which are also restricted
to ICM/EPI in expanded blastocysts, were severely reduced in
dsCtr9 embryos (Fig. 4B, control: n¼18, KD: n¼23). Fgf4 is
expressed speciﬁcally by ICM and is critical for PE formation and
TE proliferation (Frankenberg et al., 2011; Kang et al., 2013; Tanaka
et al., 1998; Yamanaka et al., 2010; Yuan et al., 1995). qPCR showed
that Fgf4 mRNA was reduced in dsCtr9 blastocysts but not at
earlier stages (not shown), likely a consequence of the absence of
nuclear SOX2 (Yuan et al., 1995). Together, these data suggest that
in the absence of CTR9, failure to repress OCT4 in the TE cells
combined with a lack of SOX2-meditated FGF4 signaling from the
ICM results in the outgrowth/TE defects.
GATA6 and SOX17 are transcription factors that are essential for
proper PE formation and differentiation (Artus et al., 2011;
Koutsourakis et al., 1999). GATA6 is initially expressed in each
blastomere in morula and then observed in a salt-and-pepper
distribution in ICM blastomeres by E3.75 (Chazaud et al., 2006).
SOX17 is initially expressed after GATA6 in small number of ICM
cells prior to E3.5 and is found coexpressed with GATA6 in PE by
E3.75 (Frum et al., 2013; Morris et al., 2010; Niakan et al., 2010). In
control embryos, GATA6 becomes highly expressed in PE cells
(high GATA6, low NANOG) although low levels of expression are
seen in some TE (Fig. 4C, upper panel, n¼21). However, GATA6
levels remain low among the majority of ICM cells in the absence
of Ctr9 (Fig. 4C, lower panel, n¼22). Additionally, the number of
NANOG positive cells is not increased in dsCtr9 ICMs, suggesting
that the compromised expression of GATA6 is not due to an
increase in NANOG (Fig. 4D). Furthermore, very few SOX17 positive
cells are present in dsCtr9 blastocysts (Fig. 4E and F, n¼14 for
dsGfp and n¼13 for dsCtr9), indicating defects in PE formation
and/or molecular patterning of ICM derivatives in dsCtr9 embryos.
Ctr9 deﬁciency leads to aberrant expression of imprinted genes
Genomic imprinting is an epigenetic phenomenon that causes
mono-allelic parent-of-origin expression of a small subset of
mammalian genes. Aberrant genomic imprinting is associated
with numerous disorders (reviewed in (Lee and Bartolomei,
2013)). Allele-speciﬁc epigenetic modiﬁcations are established in
the parental germline and must be faithfully maintained to ensure
successful development, particularly during preimplantationwhen
dramatic epigenetic reprogramming occurs. As mentioned above,
K. Zhang et al. / Developmental Biology 383 (2013) 15–27 19
Fig. 3. Depletion of CTR9 abrogates ICM identity and differentiation potential. 3 days in culture following immunosurgical removal of TE, primitive endoderm cells (yellow
arrow upper panel in A) migrate away from control ICM (red circle, upper panel in A). Very few cells (either ICM or PE) are present when Ctr9-deﬁcient ICMs are plated in
culture (A, lower panels). Scale bar: 20 μm. (B) Graph representing outgrowth potential of isolated ICM. (C) Quantiﬁcation of the number of primitive endoderm cells
observed per ICM. (D) Oct4 mRNA abundance is increased consistently beginning at the 8-cell after Ctr9 knockdown. (E,F) OCT4 protein level is enhanced in morula (15
dsGfp, 14 dsCtr9 morula examined) and trophectoderm cells of blastocysts (16 dsGfp, 25 dsCtr9 blastocysts examined) in dsCtr9 embryos. Scale bar: 50 μm. (G–I) Reduction
of Oct4 partially rescues dsCtr9 outgrowth potential (G), average outgrowth size (H) and number of trophoblast giant cells observed (I, 5 dsGfp, 9 dsCtr9, 6 dsGfpþdsOct4
embryos examined). Asterisks indicate Po0.05 by student T-test. Error bars represent SEM.
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we initially identiﬁed Ctr9 through a phenotype-driven RNAi screen
designed to identify genes required for imprinted gene expression.
Mest (Peg1) is a paternally expressed, maternally imprinted
(silent) gene, such that only paternal mRNA is detected in control
blastocysts (dsGFP, Fig. 5A). However, in dsCtr9 blastocysts we
observed biallelic Mest expression – the maternal allele was not
repressed (imprinted). We also observed a loss of imprinting (LOI)
of the paternally imprinted (maternally expressed) Meg3 transcript
(Fig. 5B). In addition to biallelic expression of Mest and Meg3, we
observed increased levels of Mest in dsCtr9 and dsRtf1 (another
component of PAF1c complex) embryos (Fig. 5C). Furthermore, we
also observed increased expression of Peg3 and Snrpn, 2 other
paternally expressed imprinted loci (Fig. 5C) in dsCtr9 blastocysts.
To determine if the loss of imprinting was due to defects in allele-
speciﬁc methylation, we examined the status of the differentially
methylated region (DMR) at the Mest and Peg3 loci. Bisulﬁte
Fig. 4. Molecular speciﬁcation of ICM/EPI and PE is abnormal in absence of Ctr9. (A) NANOG is restricted to future epiblast cells in control embryos, but is ectopically
detected in some trophectoderm cells (arrows) in dsCtr9 embryos (13 dsGfp and 21 dsCtr9 expanded blastocysts analyzed). (B) SOX2 positive cells are reduced in absence of
CTR9 (18 dsGfp and 23 dsCtr9 blastocysts analyzed). (C) GATA6 is restricted to primitive endoderm cells in control blastocysts. However, it remains expressed in the majority
of blastomeres in dsCtr9 embryos (21 dsGfp and 22 dsCtr9 expanded blastocysts analyzed). (D) The percent of ICM cells that are NANOG positive is normal and the percent of
highly expressing GATA6 (putative PE cells) cells is reduced in dsCtr9 blastocysts. (E,F) The number of SOX17 positive cells is greatly reduced in dsCtr9 expanded blastocysts
(14 dsGfp and 13 dsCtr9 embryos analyzed). Scale bars in A,B are 50 μm. Scale bars in C and E are 25 μm. Asterisks indicate Po0.05. Error bars represent SEM.
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sequencing revealed no signiﬁcant differences in overall methyla-
tion patterns between control and Ctr9 KD blastocysts (Fig. 5D).
At both DMRs, the imprinted allele was hypermethylated in control
and dsCtr9 embryos (Fig. 5D), indicating that loss of DNA methyla-
tion is not responsible for the failure to repress the maternal Peg1
and paternal Meg3 alleles in the absence of Ctr9.
Loss of histone H3K36me3 in dsCtr9 embryos
The PAF1c has been shown to be required for SET2-mediated
H3K36me3 in yeast (Chu et al., 2007). Additionally, interaction of
SET2 with elongating RNA polymerase II has been shown to be
PAF1c-dependent (Krogan et al., 2003b). Interestingly, H3K36me3
Fig. 5. Loss of imprinting in dsCTR9 blastocysts. Restriction Fragment Length Polymorphism (RFLP) assays assessed allele speciﬁc (imprinted) expression of the Mest (A) and
Meg3 (B) transcripts. Loss of imprinting was observed at both loci in dsCtr9 blastocysts where biallelic expression is obvious in ds dsCtr9 blastocysts, but control dsGFP
blastocysts show parent of origin mono-allelic (imprinted) expression as expected (only the Paternal allele of Mest, and only the Maternal allele of Meg3 are expressed in
control embryos). NTC: No template control. (C) Mest, Peg3 and Snrpn mRNA levels are signiﬁcantly increased in the absence of Ctr9 or Rtf1. Asterisks indicate Po0.05. Error
bars represent SEM. (D) Bisulﬁte sequencing ofMest (GenBank™ accession number AF017994; nucleotides 2220–2556) and Peg3 DMRs (NT_039413.7; 3683033–3682588) in
dsCtr9 and dsGfp blastocysts revealed no signiﬁcant loss of DNA methylation on the repressed allele. Note that only the maternal alleles (identiﬁed by SNP) are shown.
Paternal alleles were entirely unmenthylated as expected (not shown). Open circle: unmethylated CpG; Filled circle: methylated CpG; Asterisks indicate Po0.05. Error bars
represent SEM.
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also inﬂuences histone acetylation status by recruiting HDACs
(Keogh et al., 2005). Setd2 is detected at all preimplantation stages
with highest expression at the 2–4 cell stage (Fig. 6E). IF indicates
that H3K36me3 is localized at low levels in 8-cell embryos and
obvious in all nuclei at the morula stage (Fig. 6A). However, in
blastocysts, only a subset of cells are H3K36me3 positive (Fig. 6F),
consistent with previous reports (Boskovic et al., 2012). We found
normal expression of Setd2 in dsCtr9 embryos (Supplemental
Fig. 2). However, H3K36me3 was greatly reduced at all stages
examined in dsCtr9 embryos (Fig. 6A,B), indicating SET2-mediated
H3K36me3 in vivo requires CTR9 and is functionally conserved
from yeast to mammals. In contrast, no difference was observed in
H3K4me3 or H3K9me3 in dsCtr9 embryos (Fig. 6C,D). To examine
if embryos lacking SET2 would share phenotypic characteristics
with PAF1c components, we knocked down Setd2 by microinjec-
tion of dsSetd2 RNA. As expected, H3K36me3 signal was also
reduced after injection of dsSetd2 (Fig. 6F), and we observed
similar defects in the potential of dsSetd2 blastocysts, including
reduced outgrowth area and reduced numbers of trophoblast
giant cells per outgrowth (Fig. 6G–I). Additionally, Eomes and Elf5
are slightly reduced in dsSetd2 blastocysts, as they are in dsCtr9
embryos (Supplemental Fig. 2).
Fig. 6. CTR9 deﬁciency results in global reduction of H3K36me3 in vivo. H3K36me3 is severely reduced in dsCtr9 morula (A) and blastocysts (B) (9 control and 10 dsCtr9
morula; 9 control and 13 dsCtr9 blastocysts were analyzed). Scale bar: 50 μm. (C-D) Normal level and distribution of H3K4me3 and H3K9me3 were observed in dsCtr9
embryos at all stages examined. Scale bar: 50 μm. Knock down of Setd2 (that mediates H3K36me3) similarly compromised blastocyst outgrowth potential (E), outgrowth area
(F), as well as the number of trophoblast giant cells observed (G). Scale bar in E is 20 μm. Asterisks indicate Po0.05. Error bars represent SEM.
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Knock-down of Rtf1 phenocopies Ctr9
To conﬁrm that the defects observed in dsCtr9 embryos was
due to loss of PAF1c function, we also performed loss of function
analysis of another PAF1c member, Rtf1, which is expressed in a
similarly dynamic pattern to Ctr9 during preimplantation devel-
opment (Fig. 7A). We knocked down Rtf1 by dsRtf1 microinjec-
tion (Fig. 7B), and found normal developmental rate and
morphology in preimplantation embryos (not shown). We
observed similar outgrowth defects in Rtf1-deﬁcient blastocysts
(Fig. 7C) as well as reduced Eomes and Elf5 mRNAs (Fig. 7D).
Additionally, blastomeres with SOX2 positive nuclei were reduced
and OCT4 signal is increased in dsRtf1 blastocysts (Fig. 7F).
The similarity of dsCtr9 and dsRtf1 phenotypes strongly suggests
that the defects observed in each KD are due to disruption of
PAF1c function.
Independent knock-down of Ctr9, Rtf1 and Setd2 in early
embryos provided a unique opportunity to examine the possibility
that these PAF1c complex members transcriptionally regulate each
other's expression in vivo. We therefore examined expression of
each transcript in the absence of the others. Neither Setd2 nor Rtf1
mRNAs we altered when other PAF1c members were disrupted
(Supplementary Fig. 2A and C). However, in dsRtf1 embryos, Ctr9
mRNA was signiﬁcantly increased (Supplementary Fig. 2B) and
CTR9 protein was diminished (Fig. 7E). These results indicate that
Rtf1 is critical for the stability of CTR9 protein and suggest a
Fig. 7. dsRtf1 phenocopies dsCtr9. (A) Rtf1 mRNA is expressed in a similar pattern to Ctr9 during preimplantation development. (B) Rtf1 mRNA is efﬁciently depleted by
microinjection of dsRtf1. (C) Rtf1 deﬁciency results in compromised blastocyst outgrowth potential. Scale bar: 20 μm. (D) As in dsCtr9 embryos, Eomes and Elf5 are reduced in
the absence of Rtf1. Asterisks indicate Po0.05 signiﬁcance. Error bars represent SEM (E) SOX2 positive cells are reduced in dsRtf1 blastocysts (13 control and 17 dsRtf1
blastocysts were analyzed). Scale bar: 50 μm.
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feedback mechanism within early embryos that can modulate Ctr9
mRNA in response to CTR9 protein abundance.
Discussion
The ﬁrst lineage decision occurs during preimplantation when
reciprocal inhibition of CDX2 and OCT4 help establish and main-
tain proper ICM/TE cell fate (Niwa et al., 2005). Several transcrip-
tion factors, such as Eomes and Elf5, are required for TE lineage
differentiation and function, but are not essential for initial TE
speciﬁcation (Donnison et al., 2005; Russ et al., 2000; Zhou et al.,
2005). Here we document normal Cdx2 levels but reduced expres-
sion of Eomes and Elf5 in Ctr9 and Rtf1 depleted embryos,
suggesting that although TE is initially speciﬁed, the molecular
identity is perturbed in the absence of PAF1c. The reduced lineage
speciﬁc expression likely contributes to the failure of trophoblast
outgrowth, as Eomes-/- blastocysts fail to attach and form TE
outgrowths (Russ et al., 2000). Our ﬁndings are consistent with
experiments showing that deletion of Cdc73, another member of
PAF1, also results in a failure of TE outgrowth (Wang et al., 2008).
Additionally, the ICM of Ctr9-depleted embryos failed to pro-
liferate in isolated ICM outgrowth assays. Oct4, Nanog and Sox2 are
critical transcription factors each essential for maintaining plur-
ipotency of ICM and embryonic stem cells (Avilion et al., 2003;
Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 1998). We
observed increased Oct4 expression – both RNA and protein - in
dsCtr9 embryos, and a failure of OCT4 restriction to ICM. Ding et al.
reported that PAF1c is required to activate and maintain proper
levels of Oct4 in ES cells (Ding et al., 2009). These contrasting
results show that PAF1 regulates the Oct4 locus in both systems,
but indicates a distinction between ES cell models and in vivo ICM,
highlighting the need to conﬁrm in vitro ﬁndings in vivo. One
explanation may be a difference in the status of the cells when
PAF1c is disrupted. Ding et al. used ES cells, which have already
established and maintained appropriate epigenetic gene expres-
sion programs. Our study abrogated PAF1c function in blastomeres
in vivo, precisely during the process of epigenetic lineage speciﬁc
programming.
Nanog is normally expressed in subsets of ICM that give rise to
the epiblast after differentiation of PE. Surprisingly, NANOG is
ectopically detected in TE of dsCtr9 embryos. As with regulation of
the Oct4 locus, this result is inconsistent with Ding et al.'s ES cell
experiments, which indicate that PAF1c binds to and activates the
Nanog locus (Ding et al., 2009). However, both our data and Ding
et al. show that loss of PAF1c inhibits PE differentiation. Further
experiments will be necessary to deﬁne lineage speciﬁc relation-
ships between PAF1c and Oct4/Nanog loci, although both studies
support a role for PAF1c in PE lineage speciﬁcation and/or
differentiation.
Chromatin immunoprecipitation experiments have revealed
that H3K36me3 differentially marks the active alleles of imprinted
loci, including Dlk-Dio3, Snrpn, Grb10, Impact and Peg3 (Mikkelsen
et al., 2007). We observed increased expression of Mest, Peg3 and
Snrpn as well as DNA methylation-independent loss of imprinting
at Mest and Meg3 in the absence of Ctr9. Similar to the loss of
imprinting that we document, previous experiments have shown
that knockdown of either MBD3 and MTA2 (both NuRD complex
components) results in loss of imprinting at speciﬁc loci, including
H19(Ma et al., 2010; Reese et al., 2007). The increased locus-
speciﬁc expression that we observe in dsCtr9 embryos suggests
that during preimplantation development, PAF1c may act as a
locus speciﬁc repressor in addition to regulator of global
H3K36me3. Repression by PAF1c through recruitment of Suv39H1
(and resulting repressive histone modiﬁcations) has been shown
to occur at the cyclin D1 locus in mammalian tissue culture models
(Yang et al., 2010). Furthermore, the increase in expression of
imprinted genes that we observe in dsCtr9 embryos is greater than
2-fold, suggesting that PAF1c may contribute to appropriate
regulation of both alleles at imprinted loci. Many previous studies
have shown the critical importance of appropriate levels of
imprinted gene expression during preimplantation in both normal
and cloned embryos, and that overexpression (loss of imprinting)
can result in developmental failure in various mammals (reviewed
in (Bartolomei and Ferguson-Smith, 2011)). Interestingly, loss of
function (KO) of each of the imprinted genes that we ﬁnd over-
expressed in dsCtr9 embryos (Meg3,Mest, Peg1 and Peg3) results in
growth defects during development. However, experiments to
speciﬁcally overexpress these genes during preimplantation have
not been performed – so it remains unclear to what degree the
loss of imprinting that we observe contributes to the overall
phenotype of dsCtr9 embryos.
In yeast, it is well established that PAF1c recruits Set2 resulting
in H3K36me3 (Chu et al., 2007). Here, we have shown that
H3K36me3 is CTR9-dependent in vivo, while global levels of
H3K4me3, and H3K9me3 are not altered in dsCtr9 embryos,
indicating a speciﬁc role of PAF1c in regulation of H3K36me3 in
mammalian embryos. Although many molecular functions of
PAF1c have been documented in disparate cell types and organ-
isms, relatively little is known about the developmental role of
PAF1c in mammalian embryos. Here we have demonstrated that
CTR9 and RTF1, both components of mammalian PAF1c are
required for epigenetic events and lineage speciﬁcation and/or
function during preimplantation development (summarized in
Fig. 8). We show that CTR9 is required for H3K36me3 in vivo and
that PAF1c is required for DNA methylation-independent regula-
tion of imprinted loci during preimplantation development.
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Fig. 8. PAF1c function during early lineage decisions. Our data suggests that PAF1c
is required for molecular identity of ICM and TE cells after the ﬁrst cell fate
decision. Loss of function of CTR9 or RTF1 results in increased OCT4 and NANOG
positive TE cells, suggesting that PAF1c normally represses Oct4 and Nanog in TE.
Additionally, we document an absence of nuclear SOX2 in the ICM, indicating that
PAF1c function may be required for nuclear entry of SOX2 which also contributes to
TE and PE lineage speciﬁcation through FGF signaling. Additionally, fewer GATA6-
positive and Sox17-positive cells are present in dsCtr9 embryos suggesting that
PAF1c is required for activation of these PE markers. Together, these ﬁndings
suggest a theme that at each lineage decision, PAF1c regulates some factors that
must be repressed in pluripotent cells (OCT4, NANOG) and others that must be
activated in differentiating cells (EOMES and ELF5 in TE, GATA6 and SOX17 in PE) in
order for successful lineage decisions and function.
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Appendix A. Supplementary materials
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2013.09.005.
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